Imamura, Y., Yanagihara, K., Mizuta, Y., Seki, M., Ohno, H., Higashiyama, Y., ... & Kadota, J. I. (2004). Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells. Antimicrobial agents and chemotherapy, 48(9), 3457-3461
Hirakata, Y., Matsuda, J., Miyazaki, Y., Kamihira, S., Kawakami, S., Miyazawa, Y., ... & Turnidge, J. D. (2005). Regional variation in the prevalence of extended-spectrum β-lactamase–producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002). Diagnostic microbiology and infectious disease, 52(4), 323-329.
Hirakata, Y., Srikumar, R., Poole, K., Gotoh, N., Suematsu, T., Kohno, S., ... & Speert, D. P. (2002). Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. Journal of Experimental Medicine, 196(1), 109-118.
Hirakata, Y., Izumikawa, K., Yamaguchi, T., Takemura, H., Tanaka, H., Yoshida, R., ... & Kaku, M. (1998). Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant Gram-negative rods Carrying the Metallo-β-Lactamase Genebla IMP. Antimicrobial agents and chemotherapy, 42(8), 2006-2011.
Felmingham, D., Reinert, R. R., Hirakata, Y., & Rodloff, A. (2002). Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. Journal of Antimicrobial Chemotherapy, 50(suppl_2), 25-37.
Song, J. H., Lee, N. Y., Ichiyama, S., Yoshida, R., Hirakata, Y., Fu, W., ... & Thomas, K. (1999). Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Clinical Infectious Diseases, 28(6), 1206-1211.